Pursuant to temporary emergency legislation regarding COVID-19 in
The notice, agenda and proxy form for the AGM are available on the Investors' section of the
Dutch Translation/Nederlandse vertaling
Conform de tijdelijke noodwetgeving met betrekking tot COVID-19 in Nederland is de AVA alleen elektronisch toegankelijk. Dit betekent dat het niet mogelijk zal zijn om de AVA in persoon bij te wonen. In plaats daarvan zal de Vennootschap de aandeelhouders die zich op tijd voor de AVA hebben aangemeld, instructies geven over hoe zij verbinding kunnen maken met de virtuele AVA (alleen audio). Hoewel dit niet interactief zal zijn, zullen de aldus aangemelde aandeelhouders voor de AVA schriftelijke vragen kunnen stellen en een volmacht en steminstructies kunnen geven.
De aankondiging, agenda voor de AVA en het volmacht formulier zijn beschikbaar op de Investors sectie de
De bovenstaande tekst is een vertaling van de Engelstalige oproeping voor de AVA. Bij eventuele verschillen is de tekst van de Engelstalige oproeping altijd leidend.
About Kiadis
Founded in 1997, Kiadis is committed to developing innovative cell-based medicines for patients with life-threatening diseases. With headquarters in
Kiadis is listed on the regulated market of Euronext Amsterdam and Euronext Brussels since
Contact:
Kiadis
Director
Investor Relations & Corporate Affairs
Tel: +1 617 710-7305
M: cimino@kiadis.com
Media
LifeSpring Life Sciences Communication
Tel: +31 6 538 16 427
E: lmelens@lifespring.nl
Mary Clark
Tel: +44 203 950 9144
E: kiadis@optimumcomms.com
Kiadis Forward-Looking Statement
Certain statements, beliefs and opinions in this press release are forward-looking, which reflect Kiadis' or, as appropriate, Kiadis' officers' current expectations and projections about future events. By their nature, forward-looking statements involve a number of known and unknown risks, uncertainties and assumptions that could cause actual results, performance, achievements or events to differ materially from those expressed, anticipated or implied by the forward-looking statements. These risks, uncertainties and assumptions could adversely affect the outcome and financial effects of the plans and events described herein. A multitude of factors including, but not limited to, changes in demand, regulation, competition and technology, can cause actual events, performance, achievements or results to differ significantly from any anticipated or implied development. Forward-looking statements contained in this press release regarding past trends or activities should not be taken as a representation that such trends or activities will continue in the future. As a result, Kiadis expressly disclaims any obligation or undertaking to release any update or revisions to any forward-looking statements in this press release as a result of any change in expectations or projections, or any change in events, conditions, assumptions or circumstances on which these forward-looking statements are based. Neither Kiadis nor its advisers or representatives nor any of its subsidiary undertakings or any such person's officers or employees guarantees that the assumptions underlying such forward-looking statements are free from errors nor does either accept any responsibility for the future accuracy of the forward-looking statements contained in this press release or the actual occurrence of the anticipated or implied developments. You should not place undue reliance on forward-looking statements, which speak only as of the date of this press release.
Contact:
Phone: 978.921.4125
(C) 2021 Electronic News Publishing, source